Ankur Drugs & Pharma Ltd. - Research Center
531683 ANKURDRUGS Group (T) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 12 | Mar ' 11 | Mar ' 10 | Mar ' 09 | Mar ' 08 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 151.49 | 824.85 | 1,067.66 | 965.75 | 673.73 |
| Expenses | |||||
| Material consumed | 115.35 | 619.59 | 800.55 | 743.18 | 541.42 |
| Manufacturing expenses | 3.35 | 6.28 | 22.36 | 26.86 | 12.42 |
| Personnel expenses | 18.80 | 20.44 | 17.94 | 5.19 | 8.63 |
| Selling expenses | - | - | 2.41 | 2.26 | 0.63 |
| Adminstrative expenses | 41.90 | 44.64 | 15.20 | 8.47 | 3.29 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 179.39 | 690.95 | 858.47 | 785.96 | 566.39 |
| Operating profit | -27.90 | 133.90 | 209.19 | 179.79 | 107.33 |
| Other recurring income | 0.19 | 0.93 | 1.60 | 2.48 | 1.26 |
| Adjusted PBDIT | -27.72 | 134.83 | 210.79 | 182.27 | 108.60 |
| Financial expenses | 58.36 | 120.80 | 80.75 | 75.04 | 24.93 |
| Depreciation | 66.03 | 60.80 | 26.64 | 20.67 | 8.40 |
| Other write offs | - | - | 0.13 | 0.12 | 0.26 |
| Adjusted PBT | -152.11 | -46.77 | 103.27 | 86.44 | 75.00 |
| Tax charges | 19.02 | 22.04 | 29.07 | 21.80 | 11.51 |
| Adjusted PAT | -171.13 | -68.81 | 74.20 | 64.64 | 63.49 |
| Non recurring items | -136.37 | - | 16.73 | -27.52 | 0.01 |
| Other non cash adjustments | - | - | -4.76 | 0.01 | -0.75 |
| Reported net profit | -307.49 | -68.81 | 86.18 | 37.13 | 62.75 |
| Earnigs before appropriation | -243.68 | 63.81 | 187.75 | 126.58 | 104.35 |
| Equity dividend | - | - | 4.35 | 4.28 | 4.19 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | 0.78 | 0.73 | 0.71 |
| Retained earnings | -243.68 | 63.81 | 182.62 | 121.57 | 99.45 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis